Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Keiko Yamamoto et al.|Circulation|2025Cited by 26
The Fibronectin-Binding Integrins System as a Contributor to PAH PathogenesisSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Unknown|2023Cited by 2
Abstract 10717: Role of Integrin Signaling in Pulmonary Arterial HypertensionSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|Circulation|2021Cited by 1
Abstract 4139371: Treatment of pulmonary arterial hypertension by blocking integrin a5b1, a potential disease-modifying strategyMónica S. Montesinos, Min Lü, Sarah‐Eve Lemay et al.|Circulation|2024Cited by 0
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights from Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Mónica S. Montesinos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0